The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Project status: 
Archived

This study compares the efficacy and safety of rivaroxaban versus warfarin for the prevention of stroke and non central nervous system embolism in subjects with non-valvular atrial fibrillation.